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Highlights 
x Bioinformatic analysis of endogenous CHO promoter sequences. 
x Linking transcriptomic and genomic datasets for bioprocess-directed promoter design. 
x In silico DOE-based design method for synthetic promoter construction. 
x Design promoters exhibited 2.5-fold increase in activity over CMV-IE promoter. 
x Promoters designed to function in context of a biphasic fed-batch production process. 
 
 
Abbreviations: CHO, Chinese hamster ovary; CMV, cytomegalovirus; DOE, design of 
experiment; FPKM, fragments per kilobase of transcript per million mapped reads; GS, 
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glutamine synthetase; IVCD, integral viable cell density; ORF, open reading frame; PIC, pre-
initiation complex; qP, cell specific production rate; RNA-Seq, next-generation RNA 
sequencing; SEAP, secreted alkaline phosphatase; SV40, Simian Virus 40; TF, transcription 
factor; TFRE, transcription factor regulatory element; TSS, transcriptional start site. 
 
 
Keywords: synthetic promoter; Chinese hamster ovary cells; recombinant protein 
expression; CHO genome; transcriptomics; synthetic biology. 
 
ABSTRACT 
Synthetic promoters are an attractive alternative for use in mammalian hosts such as CHO 
cells as they can be designed de novo with user-defined functionalities. In this study, we 
describe and validate a method for bioprocess-directed design of synthetic promoters utilizing 
CHO genomic sequence information. We designed promoters with two objective features, (i) 
constitutive high-level recombinant gene transcription, and (ii) upregulated transcription 
under mild hypothermia or late-stage culture. CHO genes varying in transcriptional activity 
were selected based on a comparative analysis of RNA-Seq transcript levels in normal and 
biphasic cultures in combination with estimates of mRNA half-life from published genome 
scale datasets. Discrete transcription factor regulatory elements (TFREs) upstream of these 
genes were informatically identified and functionally screened in vitro to identify a subset of 
TFREs with the potential to support high activity recombinant gene transcription during 
biphasic cell culture processes. Two libraries of heterotypic synthetic promoters with varying 
TFRE combinations were then designed in silico that exhibited a maximal 2.5-fold increase 
in transcriptional strength over the CMV-IE promoter after transient transfection into host 
CHO-K1 cells. A subset of synthetic promoters was then used to create stable transfectant 
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pools using CHO-K1 cells under glutamine synthetase selection. Whilst not achieving the 
maximal 2.5-fold increase in productivity over stable pools harboring the CMV promoter, all 
stably transfected cells utilizing synthetic promoters exhibited increased reporter production 
² up to 1.6-fold that of cells employing CMV, both in the presence or absence of intron A 
immediately downstream of the promoter. The increased productivity of stably transfected 
cells harboring synthetic promoters was maintained during fed-batch culture, with or without 
a transition to mild hypothermia at the onset of stationary phase. Our data exemplify that it is 
important to consider both host cell and intended bioprocess contexts as design criteria in the 
de novo construction of synthetic genetic parts for mammalian cell engineering. 
1. INTRODUCTION 
Chinese hamster ovary (CHO) cells remain the most widely used cell factory for production 
of recombinant therapeutic proteins. Improvements in expression vector design and clonal 
selection methods, combined with cell and process engineering approaches (e.g. use of small-
molecules) have led to product titers in the multiple grams per liter range (Kunert and 
Reinhart 2016; Zhou et al. 2018). Of cellular synthetic processes underpinning cell specific 
production rate, recombinant transgene transcription has one of the largest impacts 
2¶&DOODJKDQHWDO6WURQJUHFRPELQDQWJHQHWUDQVFULSWLRQLQ&+2FHOOVLVVWLOO
dominated by viral sequences such as the cytomegalovirus immediate-early promoter (CMV-
IE) despite potentially undesirable attributes such as cell-cycle dependency and epigenetic 
silencing (Brightwell et al. 1997; Kim et al. 2011). Endogenous promoters such as the eIF1D 
promoters are typically relatively large which can limit transfection efficiencies or use in 
PXOWLJHQHYHFWRUV)RUH[DPSOHWKH&KLQHVHKDPVWHU()ĮSURPRWHU(Running-Deer and 
Allison 2004) supports a high level of expression but requires the use of two distinct multi-kb 
elements. 
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 Various efforts have been carried out to improve promoter characteristics in CHO 
cells. Examples include insertion of a core CpG island element (Mariati et al. 2014) and a 
CHO-K1E77 regulatory element (Kang et al. 2016) into CMV which resulted in enhanced 
stable expression. Other attempts to engineer natural promoters for increased production are 
H[HPSOLILHGYLDWKHFUHDWLRQRI³VXSHUFRUH´E\LQFRUSRUDWLQJH[WUDHOHPHQWVLQWRWKH&09
core promoter (Juven-Gershon et al. 2006) or the use oI³GXDOFRUH´E\LQVHUWLRQRIDQ
additional core sequence into CHO S100a6 promoter (Thaisuchat et al. 2011), as well as via 
truncation of a CHO endogenous promoter (Chen et al. 2013). However, these modifications 
do not eliminate the drawbacks of currently used viral promoters and engineered endogenous 
promoters, nor do they radically expand the set of existing mammalian cell engineering tools. 
In this context, synthetic promoters are an attractive alternative as they can be custom-
designed to engineer recombinant gene transcription predictably, removing functionally ill-
defined and uncontrollable elements in expression vectors. Indeed, we have previously 
reported synthetic promoters that offer stable, precise control of recombinant transcriptional 
activity in CHO cells (Brown et al. 2014, 2017). These genetic constructs were designed by 
(i) analysis of CHO cell transcription factor (TF) expression profiles, and (ii) determination 
of the transcription factor regulatory element (TFRE) compositions of commonly utilized 
viral promoters. However, no previous studies have analyzed CHO genomic sequences to 
identify active sequence motifs associated with endogenous promoters. We hypothesized that 
mining CHO genomic information (e.g. Xu et al. 2011) would identify new transcriptionally 
active TFREs to enable the design of synthetic promoters with novel functionalities. 
Whilst it is known that thousands of endogenous promoters function together to 
define the transcriptional landscape of mammalian cells (Carninci et al. 2006), it is still a 
considerable challenge to identify specific genomic regulatory elements that may be utilized 
to control expression of heterologous recombinant genes in a specific context. For example, 
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CHO cells undergo physiological transitions during a cell culture process associated with 
discrete alterations in cellular transcriptional activity. Thus we aimed to create a workflow 
based on bioprocess-relevant CHO genomic information to identify homologous regulatory 
elements that could be used to design synthetic promoters specifically useful for CHO cell 
based production processes. Synthetic promoters for mammalian systems have been 
constructed from endogenous (human) sequence components, but the expression levels 
observed were still below or only comparable to that of CMV (Cheng and Alper 2016), and 
there is no information on how we can specifically design promoters to function in a 
biomanufacturing setting (e.g. a biphasic process). The data from Cheng and Alper (2016) 
implied that each host cell system requires a bespoke synthetic promoter for optimal 
expression. In this regard, recent advancements in next-generation sequencing technology 
and CHO reference genome annotations (Wright and Estes 2014) represent a novel tool for 
construction of synthetic promoters with functionally predictable characteristics. 
 In this study we describe a procedure to mine CHO genomic information to design 
synthetic promoters that can support high-level, biphasic recombinant protein production. 
Through systematic bioinforPDWLFDQDO\VLVRIµRPLFGDWDVWUHDPVDQGin vitro screening we 
identified novel CHO endogenous TFREs that are potentially active under different 
bioprocess conditions. Based on this, we utilized an in silico experimental design strategy to 
efficiently construct synthetic promoters that harness CHO cell transcriptional capacity. We 
were able to construct, for the first time, synthetic promoters exhibiting upregulated activity 
during a biphasic production process, generating an increased titer of recombinant protein 
over that obtained using a CMV promoter. Additionally, analysis of stable transfectants 
UHYHDOHGWKDWV\QWKHWLFSURPRWHUVFDQEHGHVLJQHGZLWKPLQLPDO³SURPRWHU±promoter 
LQWHUIHUHQFH´WKDWDUHFRPSDWLEOHZLWKWKHXVHRILQWURQV:KLOVWWKLVVWXG\Gemonstrates 
effective de novo creation of optimized, bespoke promoters for CHO cell based 
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biomanufacturing, we anticipate that similar approaches could be used to create synthetic 
promoters for diverse other applications requiring expression of recombinant genes in 
mammalian cells. 
 
2. MATERIALS AND METHODS 
2.1 RNA-Seq and in silico Analysis of Transcription Factor Regulatory Elements 
RNA-Seq FASTQ data of duplicate CHO-K1SV fed-batch bioreactor cultures at different 
time points (Days 4, 9 and 11) and under different conditions (constant 37°C and a 
temperature shift to 32°C at Day 7) were provided by Biogen (Cambridge, MA). Galaxy 
(usegalaxy.org) and R software were used to analyze the RNA-Seq data according to Trapnell 
et al. (2012) using CHO-K1 GFF3 and FASTA files (RefSeq 2014) from 
ZZZ&+2JHQRPHRUJDVZHOODV%LRJHQ¶VLQ-house CHO-K1 GTF and FASTA files. The 
transcriptional activity, Ta, of a gene was calculated as follows: 
Ta = kdm = (ln 2 / t1/2)m (Eq. 1) 
where kd is the mRNA decay rate constant (h-1), m is the mRNA transcript abundance 
(FPKM) and t1/2 is the mRNA half-life (h). kd and t1/2 values were derived from 
Schwanhäusser et al. (2011) and Sharova et al. (2009) (see below and Supplementary Figure 
67UDQVFULSWLRQDOVWDUWVLWHV766VZHUHGHWHUPLQHGXVLQJDQQRWDWHG¶875VDQG
Genomatix Gene Regulation software suite (MatInspector Release 8.2 and MatBase Version 
9.3; Genomatix, Munich, Germany) was XVHGWRDQDO\]HWKHUHJLRQ(씀1WRUHODWLYHWR
the TSS against Genomatix-defined mouse promoter background to find putative 
transcription factor regulatory elements (TFREs). 
 
2.2 TFRE-Reporter Vector Construction 
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A minimal hCMV-IE1 core promoter from the human cytomegalovirus (CMV) was 
synthesized (Eurofins Genomics, Ebersberg, Germany), PCR amplified (Phusion high-
fidelity DNA polymerase; NEB, Hitchin, UK), and purified (QIAquick PCR Purification kit; 
Qiagen, Crawley, UK). The PCR products were then digested with HindIII and EcoRI 
enzymes (NEB), gel extracted (QIAquick Gel Extraction kit; Qiagen) and inserted directly 
upstream of the secreted alkaline phosphatase (SEAP) open reading frame (ORF) of a 
promoterless pSEAP2-Basic vector (Clontech, Oxford, UK). The CMV core promoter 
VHTXHQFHXVHGZDVDVIROORZV¶-
AGGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCC
ATCCACGCTGTTTTGACCTCCATAGAAGAC-¶ 
To create TFRE reporter plasmids, synthetic oligonucleotides containing 6× repeat 
copies of the TFRE consensus sequences in Table 1 were synthesized, PCR amplified and 
inserted into KpnI and HindIII sites upstream of the CMV core promoter. To create core 
promoter TFRE reporter plasmids, the CMV core promoter sequence between +19 and +39 
relative to the TSS was replaced by MTE and DPE consensus sequences (Table 1). Mutation 
of TATA-box was performed by replacing TATATAA with ACGTCCG. For example, the 
modified core promoter containing mutated TATA-box, MTE and DPE (changes underlined) 
ZDVDVIROORZV¶-
AGGTCACGTCCGGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCC
GAGCGGAGCAGACGTGCCTCCATAGAAGAC-¶&RUHSURPRWHUVZHUHV\QWKHVL]HGDQG
inserted directly upstream of the SEAP ORF of a promoterless pSEAP2-Basic vector as 
described above. Clonally derived plasmids were purified using a QIAGEN Plasmid Midi kit 
(Qiagen). The sequence of all plasmid constructs were confirmed by DNA sequencing. 
 
2.3 Synthetic Promoter Construction 
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To create synthetic promoters, synthetic genes containing combinations of specific TFREs 
were designed in silico (Design-Expert 10; Stat-Ease, Minneapolis, MN) using two-level 
factorial designs (reduced two-factor interaction models; Table 2). The positions of the TFRE 
blocks within the promoters were randomly arranged using R software in forward orientation 
RI¶'1$VWUDQG6\QWKHWLFJHQHVZHUHV\QWKHVL]HG(XURILQV*HQRPLFVDQGLQVHUWHGLQWR
KpnI and HindIII sites upstream of the CMV core promoter. A full length CMV promoter 
containing the same CMV core íWR50 relative to the TSS) was also synthesized and 
inserted into KpnI and EcoRI sites upstream of the SEAP ORF. The pSEAP2-Control vector 
harboring a Simian Virus (SV40) early promoter/enhancer was obtained from Clontech. The 
sequence of all plasmid constructs was confirmed by DNA sequencing. 
2.4 CHO Cell Culture 
A GSíí CHO-K1SV cell line was provided by Biogen. Cells were cultured in Biogen 
proprietary medium supplemented with 6 mM L-glutamine (Sigma, Poole, UK) in 
Erlenmeyer flasks (Corning, Acton, MA) maintained at 37°C, 140 rpm under 5% CO2. Sub-
cultures were seeded at 2×105 viable cells mL-1 every 3±4 days. Cell concentration and 
viability were measured using a Vi-CELL XR (Beckman Coulter, Brea, CA). 
 
2.5 Transient Transfection 
Transfections were conducted using an Amaxa Cell Line Nucleofector Kit V system (Lonza, 
Basel, Switzerland) as previously described (Johari et al. 2015). 5×106 cells per cuvette were 
electroporated with 4±ȝJ'1$DQGWUDQVIHUUHGWRD7XEH6SLQELRUHDFWRUWXEH733
Trasadingen, Switzerland) containing 10 mL pre-warmed culture media. Transfected cells 
were cultured for 48 h at 37°C, 170 rpm under 5% CO2. To determine transfection efficiency, 
cells were transfected with pmaxGFP vector (Lonza) using the same procedure and analyzed 
using Attune Acoustic Focusing Cytometer (Thermo Fisher, Waltham, MA). 
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2.6 Generation of Stable Pools 
A pEE12.4 vector containing an SV40 promoter-driven glutamine synthetase (GS) gene was 
provided by Biogen. To create the stable expression vectors, the SEAP gene was cloned by 
PCR (Q5 high-fidelity 2× master mix; NEB) and inserted into BsiWI and EcoRI sites, the 
minimal CMV core promoter was cloned without or with an 898 bp CMV intron A 
downstream of the core and inserted into HindIII and BsiWI sites upstream of the SEAP 
ORF, and the synthetic genes of the synthetic promoters were cloned and inserted into BsrGI 
and HindIII sites upstream of the CMV core promoter. All vector constructs were confirmed 
by sequencing. Stable transfections were conducted using circular plasmids and Amaxa Cell 
Line Nucleofector Kit V system as described above. Transfected cells were transferred to a 
TubeSpin bioreactor tube containing 10 mL glutamine-free media and cultured at 37°C, 170 
rpm under 5% CO2 with media change every 3±4 days until the cell viability reached >95% 
and then cryopreserved. 
 
2.7 Fed-Batch Stable Production 
CHO cells were revived and cultured as described above for three passages prior to fed-batch 
production. Cells were seeded at 4×105 viable cells mL-1 into 125 mL Erlenmeyer flasks at a 
working volume of 28 mL using Biogen proprietary medium supplemented with anti-
clumping agent (Life Technologies) at 1:250 (v/v) dilution. Fed-batch cultures were 
maintained at 37°C, 140 rpm under 5% CO2 and 75% humidity for 10±11 days until cell 
viability dropped below 80%. Daily nutrient supplementation was performed using a total of 
35±40% (v/v) Biogen proprietary feed throughout culture. For cultures maintained at reduced 
culture temperature, cells were shifted to 32°C on Day 6. 
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2.8 Determination of Recombinant SEAP Production 
Prior to analysis, culture medium was filtered through a 0.45 µm Spin-X centrifuge tube filter 
(Sigma). SEAP concentration was measured using SensoLyte pNPP Alkaline Phosphatase 
$VVD\NLW$QD6SHF)UHPRQW&$DFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQVThe cell 
specific production rate (qP) was calculated as described in 2¶&DOODJKDn et al. (2010). 
 
2.9 Measurement of Recombinant SEAP mRNA Copy Number 
1.5×106 viable cells were collected by centrifugation at 200×g for 5 min. Cell pellets were 
immediately resuspended in 300 µL of RNAprotect Cell Reagent (Qiagen) and stored at 4°C. 
Total RNA was extracted using RNeasy Plus Mini kit in combination with QIAshredder 
KRPRJHQL]HU4LDJHQDFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQVJ'1$-free RNA was 
converted to cDNA and quantified by one-step RT-PCR using an Applied Biosystems 7500 
Fast Real-Time PCR system (Thermo Fisher) by the relative quantification method. Reverse 
transcription and PCR reactions were performed in a final volume of 25 µL using Power 
SYBR Green RNA-to-CT 1-Step kit (Thermo Fisher), containing 0.5 µL of RNA and 100 nM 
of forward and reverse primer each. Primers were designed using Applied Biosystems Primer 
([SUHVVVRIWZDUH7KHUPR)LVKHUDVIROORZV6($3)ZG¶-
CCATATGTGGCTCTGTCCAA-¶5HY¶-GTCTGGAAGTTGCCCTTGAC-¶*6)ZG
¶-CGCAGAGATCCCAACAAGCT-¶*65HY¶-TGCAGGCTTCCGGTTGTACT-¶
DQG*$3'+)ZG¶-TGCCACCCAGAAGACTGTG-¶5HY¶-
GTGGATGCAGGGATGATGTT-¶7KH3&5WKHUPDOF\FOHSURILOHZDVDVIROORZV&
for 30 min; 95°C for 10 min; 40 cycles of 95°C for 15 s, and 60°C for 1 min; followed by 
melt curve analysis to confirm the specificity of amplification. Relative SEAP gene 
expression was determined using the ǻǻCt method normalized to endogenous GAPDH 
mRNA levels. 
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3. RESULTS 
3.1 Bioinformatic Identification of Transcription Factor Regulatory Elements in CHO-
K1 Endogenous Promoters 
The level of transcriptional activation mediated by a discrete promoter sequence is largely 
determined by its unique composition of TFREs, and the availability of cognate TFs. 
Accordingly, design rules for constructing synthetic elements with desired functionalities can 
be obtained by either (i) determination of host cell TF repertoires under appropriate 
experimental conditions, or (ii) analysis of TFRE compositions of endogenous promoters 
exhibiting suitable expression dynamics. Whilst synthetic promoters have been created for 
CHO cells by analysis of TF expression levels (Brown et al. 2017), CHO genomic (i.e. 
endogenous TFRE) information has never been utilized, potentially limiting opportunities for 
synthetic promoter design. We therefore devised a methodical, comprehensive approach for 
informed design of synthetic promoters based on CHO genomic sequence information 
(summarized in Figure 1). This work flow enables identification of endogenous gene 
promoters (and associated TFREs) with desirable functional features, thus allowing de novo 
design of synthetic promoters with related, bioprocess-relevant characteristics. To profile 
endogenous gene expression in CHO cells, we generated RNA-Seq data (Figure 1, Step 1) 
using CHO-K1SV fed-batch bioreactor cultures sampled at Days 4, 9 and 11 post-inoculation 
with and without a shift to 32°C at Day 7. Bioinformatic analysis (Figure 1, Step 2) was 
performed with two objectives; (i) to identify genes with high transcriptional activity 
(FPKM/h) at different culture phases/temperature, and (ii) to identify potentially active CHO 
genomic TFREs upstream of genes varying in transcriptional activity. Based on RNA-Seq 
differential gene expression analysis of ~27,600 annotated CHO-K1 genes, most changes in 
mRNA transcript abundance (q < 0.05) were observed between log (Day 4) and stationary 
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(Day 9) phases of culture, where 13.2% of the genes were upregulated and 13.8% were 
downregulated. In contrast, comparison of mRNA abundance in cells under hypothermic or 
normal culture conditions (Day 9, 32°C vs. Day 9, 37°C) identified only relatively minor 
changes in gene expressions (2.6% upregulated and 3.6% downregulated). There were no 
apparent changes in mRNA abXQGDQFH(씀0XSGRZQUHJXODWHGEHWZHHQHDUO\
stationary (Day 9) and late stationary (Day 11) phases for both 37°C and 32°C cultures. 
With respect to the second objective (identification of active endogenous TRFEs), it 
was necessary to quantify the relative transcriptional activity of CHO genes. As the 
abundance of a given mRNA is a function of both gene transcription and mRNA decay rates 
(Cheadle et al. 2005; where the latter can vary between ~1 and 30 h), in order to compare the 
transcriptional activity of CHO genes we estimated CHO mRNA stabilities based on 
published data for other mammalian cells, as none exists for CHO cells at the genome scale.  
Averaged mRNA half-lives deriving from empirical analyses of murine NIH3T3 and 
embryonic stem cells from Schwanhäusser et al. (2011) and Sharova et al. (2009) 
respectively were used to estimate and rank the relative transcriptional activities (expressed 
as FPKM/h; Equation 1) of ~7,600 CHO genes. We note that there was a very significant 
(albeit weak) correlation between the two half-life datasets (r = 0.492, p < 2.2×10-16; 
Supplementary Figure S1). We acknowledge that it may be expected that (in general) mRNA 
stability will change for cells exposed to mild hypothermia. However, in the absence of any 
genome-scale datasets we assumed for the purpose of this analysis that the stability of CHO 
mRNAs at 32qC was generally proportionate to that observed at 37°C. 
Further analysis of the top 1% of genes with high transcriptional activity revealed that 
most exhibited a decrease from log to stationary phase but exhibited no significant change 
when shifted from 37°C to 32°C (data not shown). In order to identify TFREs that were also 
active at stationary phase and under hypothermia, the top 200 genes from each 
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phase/condition (i.e. Day 4; Day 9, 37°C; and Day 9, 32°C) were selected. A subset of 50 
genes that occurred in all three datasets was then selected to form a high transcriptional 
activity group. Corresponding medium and low transcriptional activity groups were created 
by selection of the mid 50 genes (exhibiting a median level of transcriptional activity) and 
bottom 50 genes with Ta > 0.0005 FPKM/h of the ranked genes, respectively. Supplementary 
Table S1 lists the selected genes in each group. We note that the largest fold change increases 
in transcriptional activity (during log to stationary, or 37°C to 32°C) occurred in genes with 
very low transcriptional activity (which still remained low), hence providing less useful 
information for design of active synthetic promoters (data not shown). 
For each selected CHO gene, a transcriptional start site (TSS) was estimated based on 
DQQRWDWHG&+2¶875VHTXHQFHV:Hnote that available in silico TSS prediction tools were 
largely inaccurate (Abeel et al. 2009) whilst experimentally verified annotation of CHO TSSs 
(e.g. using RNA-Seq method; Jakobi et al. 2014) was still in infancy. Relative to the TSS a 
í1000 to +200 bp segment was extracted from the CHO genomic sequences for putative 
TFRE analysis. TFRE identification (Figure 1, Step 3) was performed using the Genomatix 
Overrepresented TFBS (MatInspector/MatBase) tool against a murine promoter background 
with the promoter Z-score threshold set to >2.0 (p < 0.05). The result revealed 144, 93 and 72 
discrete TFREs in the high, medium and low transcriptional activity groups respectively. To 
minimize false positives (i.e. inactive TFREs; Figure 1, Step 4) in the high activity group, we 
filtered out TFREs that also occurred in the medium/low activity group (Figure 2) as well as 
non-FRQVHUYHG7)5(VWKDWRFFXUUHGRQO\LQRIJHQHV7RIXUWKHU7)5(SRRO
complexity, we selected only up to 2 TFREs with the highest Z-scores from each TF family. 
Table 1 lists the final set of 32 TFREs incorporated into the functional screen, where 29 
TFREs were enhancer elements and 3 TFREs were core promoter elements. The TF 
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matrix/family, frequency and Z-score of the selected TFREs are detailed in Supplementary 
Table S2. 
 
3.2 Determination of Transcription Factor Regulatory Element Activity in CHO Cells 
The relative transcriptional activity of each enhancer TFRE (Table 1) in CHO-K1SV cells 
was determined as previously described (Brown et al. 2014) using a SEAP reporter construct 
that contained six repeat copies of a specific TFRE in series, upstream of a minimal hCMV-
,(FRUHSURPRWHU(씀3WR relative to the TSS, containing a TATA box and an Inr motif). 
Transient transfection of plasmid DNA by nucleofection yielded transfection efficiency of 
~94% (measured using a vector encoding GFP, flow cytometry data not shown). 
Measurement of SEAP expression deriving from transfection of each TFRE-reporter plasmid 
after 48 h culture post-transfection is shown in Figure 3A. This analysis identified 11 TFREs 
that significantly increased expression (>5-fold) over basal expression from the minimal core 
promoter (NFțB, NFțB-p65, *$%3ȕ'03$K5$51786)67$76S=%('
3D[DQG(*5. Amongst these, only 3 TFREs ² NFțB, USF1 (E-box) and Sp1 (GC-box) 
have been identified for our previous viral- and TF-derived synthetic promoter constructs 
(where the former was the most active element in CHO cells; Brown et al. 2014, 2017). 
Therefore identification of CHO genomic TRFEs significantly expanded the CHO synthetic 
promoter design toolbox. As there were no correlations with respect to the specific TFRE 
frequency of occurrence in the high activity group (Supplementary Table S2), we infer that 
gene transcriptional activity is largely a function of the context-specific mechanism of 
discrete TF-mediated transcriptional activation and/or affinity of a given TF for its cognate 
TFRE. In summary, this screening exercise yielded a pool of transcriptionally active TFREs 
that were subsequently used to construct synthetic promoters. 
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5HJXODWRU\HOHPHQWVZLWKLQFRUHSURPRWHUUHJLRQVW\SLFDOO\íWRUHODWLYHWR
the TSS) bind cognate general TFs to form transcription pre-initiation complexes (PICs). It 
was hypothesized that optimized core promoter functionality would be achieved by 
maximizing core regulatory element numbers, where these elements function synergistically 
to increase transcription initiation rates (Juven-Gershon and Kadonaga 2010). To investigate 
the use of the core promoter to achieve high expression level, we created and characterized 
modified CMV core promoters that contain TATA, Inr, MTE and/or DPE motifs. The 
synthetic MTE and DPE elements were incorporated into core promoters with strictly 
maintained spacing from Inr, i.e. at +19 and +30 relative to the TSS (Kutach and Kadonaga 
2000; Lim et al. 2004). As TATA boxes were not identified in our bioinformatic analysis, we 
also created TATA-less core promoters by mutating the element as described in Lim et al. 
(2004). The core promoters were each subcloned into a promoterless vector with a SEAP 
reporter gene. The core promoter activity (in absence of enhancer elements) after 48 h culture 
is shown in Figure 3B. This analysis shows that the MTE+DPE core did not significantly 
improve the basal expression of CMV core with <2-fold increment observed (compared to up 
to 63-fold increase achieved by enhancer elements), whilst mutating the TATA box led to a 
55% reduction in core basal expression. When combined with a CMV enhancer, the best 
modified core promoter (MTE+DPE) yielded a similar SEAP productivity compared to the 
wild-type CMV core (data not shown). This is possibly due to TF±TFRE interactions within 
enhancers decreasing the influence of core-mediated processes such as PIC formation and 
transcription initiation (Juven-Gershon and Kadonaga 2010). We conclude that the efficacy 
of core promoter engineering is much more limited compared to enhancer region engineering, 
and that synthetic core promoters would need to exhibit considerably improved functionality 
to replace the CMV core in synthetic promoter libraries. 
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3.3 Construction of Strong Synthetic Promoters using Design-of-Experiments Reveals 
CHO Intrinsic Transcriptional Capacity 
Given our previous finding that mammalian synthetic promoters can be constructed 
according to relatively simple design rules (Brown et al. 2017), we hypothesized that we 
could build promoters (i.e. TFRE combinations) in silico, obviating the requirement to screen 
hundreds of randomly assembled TFRE compositions. To test this, a two-level fractional 
factorial design was employed to systematically construct synthetic promoters containing 
different combinations of TFRE blocks. This design was chosen as it assumes that interaction 
effects between two or more variables are small as compared to main effects, and importantly 
allows analysis of many different factors (TFREs) using a limited number of experiments 
(promoter variants) which can then be projected into stronger designs using a subset of the 
significant factors (Carlson and Carlson 2005). In order to create strong synthetic promoters 
we utilized the TFREs identified as transcriptionally active in CHO-K1SV cells (Figure 3A) 
with bias towards highly active TFREs. To reduce the design space only one TFRE from each 
family was utilized (e.g. NFțB-p65 subunit was omitted), as well as the less active ZBED1, 
Pax3 and EGR-1 TFREs. With respect to the former, we reasoned that the use of TFREs from 
GLIIHUHQW7)IDPLOLHVPD\KDYHDGYDQWDJHRXV³PRGXODU´FRPELQDWRULDOHIIHFWV(Cartharius et 
al. 2005), whereas NFțB and its p65 subunit might induce transcription in a similar manner. 
Based on our previous work we also employed the following design rules: (i) maximum copy 
number of any discrete TFRE = 6 (i.e. to minimize off-target effects on host cell performance 
(Brown et al. 2017), (ii) copy number of Sp1 per promoter = 1 (small quantities of Sp1 
having been shown to support high transcriptional activities within heterogeneous promoter 
architectures (Brown et al. 2014)), and (iii) the relative order of constituent TFREs was 
random, separated by minimal spacers (Brown et al. 2017).  
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Nine synthetic promoter constructs with the varying TFRE compositions shown in 
Table 2 (Library 1) were chemically synthesized and inserted upstream of the minimal CMV 
core promoter in SEAP reporter plasmids. A control CMV promoter reporter plasmid was 
constructed using the CMV-,(SURPRWHU(씀6WR50 relative to the TSS, i.e., the complete 
hCMV-IE1 enhancer containing the distal, proximal and core promoter regions, henceforth 
referred to as CMV) upstream of the SEAP ORF. The commonly used Simian Virus 40 
(SV40) early promoter/enhancer (henceforth referred to as SV40) was also tested as a 
comparison. To ensure that SEAP production kinetics were not affected by recombinant 
DNA overload (Johari et al. 2015), cells were transfected with a 33% lower DNA dosage 
compared to the TFRE screening process. The transient SEAP production and mRNA data 
(Figure 4A) shows that all Library 1 synthetic promoters yielded very strong reporter 
expression, where the least active promoter (1/01) achieved a cell specific SEAP production 
rate (qP) similar to that observed for the CMV control vector which is over twice the size of 
1/01. The strongest Library 1 synthetic promoter (1/09) exhibited a 2.5-fold or 8.3-fold 
increase in transcriptional activity compared to the CMV and SV40 promoters respectively. 
Again, this promoter (473 bp) is 25% smaller than CMV, indicative of far more efficient 
transcriptional activation under these assay conditions. However, the data in Figure 4A also 
indicate that synthetic promoter mediated transcription becomes saturated as it approaches a 
level ~2.5-fold greater than that exhibited by the CMV promoter. For example, promoter 
1/09, which contains 50% more TFRE blocks than promoter 1/05 (Table 2), displayed only a 
16% increase in expression. 
To investigate the relative activity, as well as synergism between TFREs we 
performed a design-of-H[SHULPHQW'2(DQDO\VLVXVLQJµORJLW WUDQVIRUPDWLRQ¶WRHPXODWH
saturation of reporter expression by setting the upper bound transcriptional output to a value 
equivalent to 2.5-fold the activity of the CMV promoter. Table 3 (Library 1) summarizes the 
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reduced two-factor interaction model emplR\HGZLWKDQLQFRQVHTXHQWLDO1)ț%±STAT3 
interaction parameter removed to improve model fit. Highly significant model was obtained 
(p IRUWKLVILUVWOLEUDU\ZLWKDQLQVLJQLILFDQW³ODFNRIILW´LQGLFDWLQJFRPSDUDEOH
variance of modeled and empirical data. Additionally, the model achieved a good agreement 
between the predicted and adjusted R2 values (<0.2 difference) validating the reliability of the 
model in predicting the output response to the combination of effectors. The model for this 
first library derived from the relative qP analysis in terms of TFRE block numbers is as 
follows: 
T3 1)ț%*$%3ȕ'03$K5$51786)
+ 0.07(STAT3) + 1.20 (Eq. 2) 
The positive parameter coefficients indicate that all TFREs functioned as transactivators of 
UHSRUWHUJHQHH[SUHVVLRQ$GGLWLRQDOO\WKHVWDWLVWLFDODQDO\VLVFRQILUPHGWKDW1)ț%*$%3ȕ
and to a lesser extent DMP1 significantly influenced expression (p < 0.05; Table 3, Library 1) 
although it is possible that these were contributed by positive interactions of two discrete 
TFREs (see the alias structure in Table 3). In contrast, AhR/ARNT, USF1 and STAT3 were 
insignificant factors (p > 0.05; partly due to the fewer block numbers) which also indirectly 
indicate that therHZHUHQRVLJQLILFDQWLQWHUDFWLRQVDPRQJWKHVWURQJ7)5(V1)ț%*$%3ȕ
DMP1) or among the weak TFREs (AhR/ARNT, USF1, STAT3).  
Derived from the analysis of Library 1 promoters, we created a second library of 
promoters in an effort to augment the transcriptional activity which could be achieved by 
further biasing the components towards highly significant (active) TFREs. Specifically, eight 
promoters were constructed using a two-level fractional factorial design with the block 
number of highly significant NFț%DQG*$%3ȕLQFUHDVHGWRVHYHQZKLOHWKHQXPEHURI
DMP1 and AhR/ARNT blocks made constant at mid-levels (4 and 2 block copies, 
respectively) and Sp1 omitted. Two additional promoter constructs (2/09 and 2/10) favoring 
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1)ț%*$%3ȕ'03DQG$K5$517ZHUHalso constructed. Library 2 synthetic promoters 
were created as described previously and their TFRE block compositions are listed in Table 
2. The relative transcriptional activity of Library 2 promoters is shown in Figure 4B. These 
promoters exhibited increased activity with the mean expression level (relative to CMV) 
shifted from 1.9-fold for first library to 2.1-fold for Library 2 promoters. However, as per 
Library 1, reporter expression saturated at ~2.5-fold CMV, implying that the synthetic 
promoters had reached the limit of CHO-intrinsic transactivation capacity under these 
conditions. The model for the second library promoters derived from the relative qP analysis 
in terms of TFRE block numbers is as follows: 
T3 1)ț%*$%3ȕ86)+ 0.41(STAT3) + 0.57 (Eq. 3) 
The statistical analysis (Table 3/LEUDU\FRQILUPHGWKDW1)ț%DQG*$%3ȕZHUHWKHPRVW
active contributors to the gene expression (with no confounding factors). USF1 and STAT3 
remained insignificant factors although these elHPHQWVZHUHVWLOOUHTXLUHGIRUVWURQJ³EDVDO´
expression relative to CMV. Despite the higher model resolution (alias structure), the analysis 
also indicated that the TFRE interaction parameters were insignificant and thus were removed 
in order to improve model fitness. Combining all observations made above, we conclude that 
promoter strength is primarily a function of (i) transcriptional activation mechanism of a 
specific TFRE, and (ii) copy number of a specific TFRE ² corroborating our previous TF-
based promoter designs (Brown et al. 2017). 
 
3.4 Analysis of Synthetic Promoter Function for Stable Recombinant Protein 
Production 
In order to determine if synthetic promoters can be deployed in a stable expression format 
and operate effectively under different culture conditions/phases, we generated stably 
transfected pools of CHO cells and evaluated their relative functional activity through a 
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biphasic fed-batch production process. Stable transfectant pools (rather than clonally derived 
populations) were employed to compare the relative stable activity of synthetic promoters as 
they provide a population average readout of synthetic promoter transactivation with less 
interference from integration-specific effects and clone-to-clone phenotypic variation. 
Further, prHYLRXVVWXGLHVKDYHVKRZQWKDWWKHXVHRI¶LQWURQLPPHGLDWHO\GRZQVWUHDPRI
transcriptional start site can augment CMV promoter-driven recombinant protein production 
(Mariati et al. 2010) where they function as translation-enhancing elements (Skoko et al. 
2011). We therefore examined the effects of a wild-type CMV promoter intron A when 
coupled with synthetic promoters for stable SEAP expression. We hypothesized that intronic 
sequence downstream of a synthetic promoter influenced transcriptional activity and/or gene 
expression generally. A panel of four strong synthetic promoters with varying TFRE 
composition were selected (specifically promoters 1/05, 1/08, 1/09 and 2/08), and these were 
inserted into the pEE12.4 stable vector backbone encoding SEAP either with or without an 
898 bp intron A immediately downstream of the promoter. Vector constructs encoded 
glutamine synthetase (GS) under the control of an SV40 promoter as the selectable marker in 
the GSíí (knockout) host cell line. We note that promoter 2/10, despite its distinctive 
composition (Table 2), could not be tested for stable performance due to protracted gene 
synthesis turnaround (~3 months) that arose from sequence-specific DNA synthesis 
difficulties. This emphasizes a potentially unforeseen issue in synthetic biology, i.e. difficulty 
in chemical synthesis when contextual sequence is varied. 
 Four transfection pools for each promoter were created, with host cell viability 2 h 
post-transfection ranging from 79 to 83% (data not shown). During the selection process in 
glutamine-free medium, we observed that all cell populations that employed synthetic 
promoters had a better recovery rate compared to both CMV populations, either with or 
without intron A (Figure 5A). Whilst cell viability across all stable pools was similar at 24 h 
AC
CE
PT
ED
 M
AN
US
CR
IPT
21 
 
post transfection (50±6%), CHO cell populations transfected with constructs harboring 
synthetic promoters achieved a ~26% higher viability at 7 days post-transfection than cells 
transfected with CMV promoter constructs and were fully recovered by Day 13 (viability 
>95%) compared to CMV pools which were recovered by Day 15. 
Stable SEAP production during a 4-day batch culture was measured after the fourth 
passage post-cell revival. Whilst nearly all cell populations transfected with synthetic 
promoters exhibited stable SEAP production in excess of that observed from cells stably 
transfected with the CMV promoters, the extent to which SEAP production was increased 
relative to that deriving from CMV containing vectors was not as substantial as previously 
observed for transiently transfected cells (Figure 4). For example, SEAP production from cell 
WUDQVIHFWHGZLWKV\QWKHWLFSURPRWHUíLQWURQ$ZDVRQO\-fold that of cells 
WUDQVIHFWHGZLWK&09íLQWURQ$LQVWDEOHPRGHUDWKHr than 2.5-fold that of CMV in 
transient mode (Figure 4). Nevertheless, three of the synthetic promoters tested (1/08, 1/09 
and 2/08) still demonstrated a significant increase in reporter production over CMV. 
Comparison of SEAP production by cells transfected with promoters upstream of intron A 
FRPSDUHGWRWKHLULQWURQOHVVíFRXQWHUSDUWVXVLQJDWZR-tailed t-test revealed no 
significant differences in all cases (p )LJXUH%This was not completely unexpected 
as previous studies showed that although CMV(+intron A) generally performed better, the 
effects were also protein-dependent (Chapman et al. 1991). Whilst this study suggests that 
posttranscriptional SEAP mRNA processing was not a critical factor affecting productivity 
under these conditions, it also indicates that introns may be employed downstream of 
synthetic promoters with no detrimental effects. 
As stable productivity mediated by synthetic promoters (relative to that mediated by 
CMV) was below that predicted by transient transfection, coupled with the observation that 
cells transfected with synthetic promoters recovered growth more rapidly, we tested the 
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hypothesis that the more complex CMV promoter repressed SV40 mediated transcription of 
the GS selection marker via promoter-promoter interference (Curtin et al. 2008) to a greater 
extent than synthetic promoters. This would result in reduced GS mRNA in CMV-transfected 
cells associated with more stringent coupling of recombinant gene transcription to cell growth 
(Fan et al. 2013). Therefore, we further quantified SEAP and GS mRNA levels in a subset of 
stable transfectants (all lacking intron A) by qRT-PCR. This analysis (Figure 5C) revealed 
that GS mRNA copy number was generally about 96% less than SEAP mRNA copy number 
when these two promoters were utilized together to create stable transfectants. Even 
considering potential differences in SEAP and GS mRNA stability, this is significantly less 
GS mRNA than would be expected. For example, where CMV and SV40 promoters are 
tested separately, SV40 mediated expression is typically about one third of that obtained with 
CMV (e.g. Figure 4A). However, the abundance of GS mRNA in all synthetic promoter 
stable transfectant pools was significantly higher (between 34 to 63%) than in CMV-derived 
stable transfectants (Figure 5C). From this we infer, as we have previously reported (Davies 
et al. 2011), that the higher level of GS expression resulted in less stringency of stable 
transfectant selection, thus the better general recovery of cells transfected with synthetic 
promoters post-transfection but relatively less stable expression (relative to CMV) than 
would have been predicted by transient expression. Our data do not suggest that synthetic 
promoters do not interfere at all with other co-located promoters, but that the significant 
DGGHGFRPSOH[LW\RIWKH³QDWXUDO´&09SURPRWHUOLNHO\UHVXOWVLQPRUHSURQRXQFHG
interference. 
Lastly, we hypothesized that progression of CHO cells through a production process, 
with the associated dynamic variation in cell physiology may alter the relative abundance of 
endogenous TFs affecting synthetic promoter activity thus affecting synthetic promoter 
performance. In order to determine if the synthetic promoters displayed improved 
AC
CE
PT
ED
 M
AN
US
CR
IPT
23 
 
biomanufacturing performance, we evaluated CMV, 1/09 and 2/08 stable transfectant pools 
íLQWURQ$IRUWKHLUUHODWLYHIXQFWLRQDOFDSDELOLW\WKURXJKDQ-day fed-batch production 
process with and without a shift to 32°C at Day 6 post-inoculation (Figure 6). Stable pools 
utilizing synthetic promoters appeared to have slightly lower integral viable cell density 
(IVCD) compared to CMV although this was largely insignificant (<9%; p 
suggesting that the use of synthetic promoters specific for a small number of TFs may 
compete with the host cell genome for transactivation, thus reducing host cell proliferation 
and density. Despite the reduction in IVCD, the synthetic promoters were still more 
advantageous, particularly promoter 1/09 where it achieved 72% and 38% increases in qP at 
log phase (Day 0±6) and stationary phase (Day 6±9) respectively under normal culture 
condition. This resulted in a 1.5-fold increase in product titer (Figure 6B). We surmise the 
late stage culture performance was supported by DMP1 and Sp1 as these TFREs were found 
exclusively in a subset of 7 genes with log-to-stationary upregulation (Supplementary Table 
S1, high transcriptional activity group) during bioinformatic analysis (data not shown). 
Further, qP of cells stably transfected with promoters 1/09 and 2/08 increased when the 
culture temperature was reduced to 32°C (Figure 6B), demonstrating for the first time that 
synthetic promoters can be designed to specifically function in a biphasic production process. 
Again, despite the reduction in IVCD, the promoters achieved up to 1.3-fold increase in titer 
compared to the CMV 32°C culture, validating our selection of TFRE combinations that were 
designed to maximize productivity. These data also substantiate our general hypothesis that 
promoter activity can be specifically regulated by designing endogenous sequences to bind 
TFs with dynamic expression profiles. We anticipate that synthetic promoters constructed 
with heterogeneous mixture of TFREs specifically screened for activity in stationary phase 
and hypothermic conditions (Figure 1, Step 5), coupled with an appropriate (weak) 
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synthetic/SV40 promoter driving a selection marker, would significantly increase 
recombinant protein production. 
 
4. DISCUSSION 
In this study we have mined CHO genomic information to construct synthetic promoters 
designed specifically to function in a biphasic production process. A key feature of our work 
is the incorporation of whole bioprocess performance into synthetic promoter design. This 
method enables the construction of optimized, bespoke promoters from a vast design space 
for different biomanufacturing and synthetic biology applications using mammalian cells. For 
example, RNA-Seq analysis has revealed that different chemical inducers (sodium butyrate, 
hexamethylene bisacetamide, caffeine) have distinct impact on endogenous gene expression 
of CHO cells (Fomina-Yadlin et al. 2015) and we anticipate that bioinfomatic analysis of 
these transcriptomic datasets would potentially yield TFRE pools that are particularly useful 
for designing inducible gene-expression systems. The major challenge with such de novo 
designs is the difficulty in identifying TFREs underpinning the more complex regulation 
governing endogenous gene expression systems (e.g. synergistic activation; Matsusaka et al. 
1993) ZKLFKZRXOGUHTXLUHPDVVLYHVFUHHQVRI³GL-7)5(´DFWLYLWLHVXQGHUVSHFLILFELRSURFHVV
conditions, preventing rational selection or determination of their functionality. However, as 
the quality and volume of CHOmics data continues to increase, and, given the progressive 
development of TFRE database and analysis tools, finding such TF interactions in silico may 
indeed be tractable. 
The synthetic promoters presented in this study exhibited saturation of activity at 2.5-
fold over CMV, which we speculate (based on this and previous studies) is the maximal level 
of CHO specific recombinant gene transcription. This is likely as CMV itself is a relatively 
potent promoter where recombinant mRNA transcripts have been shown to account 16% of 
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total mRNA in the cell, and a combination of inducer treatment and hypothermic condition 
increased the expression level to up to 45% of total mRNA (Fomina-Yadlin et al. 2015). 
:KLOVWWKHODWWHULVQRWVXUSULVLQJGXHWRUDGLFDOFKDQJHVLQWKHFHOOV³WUDQVFULSWLRQDO
ODQGVFDSH´WKHIRUPHULVDOVRDYHU\VLJQLILFDQWSURSRUWLRQFRQVLGHULQJWKDW&+2FHOOV
express thousands of genes. Further, expression of many cell growth and housekeeping genes 
appears to negatively correlate to recombinant transcript levels (Fomina-Yadlin et al. 2015; 
Sha et al. 2018) suggesting that the use of recombinant gene promoter resulted in titration of 
TFs away from endogenous genes affecting their expression levels. Therefore, the strength of 
a promoter may be effectively constrained by the effects it imposes on cellular functions. 
This could partially explain the observed slight reduction in cell growth and peak VCD of 
cells employing the synthetic promoters (Figure 6A) as well as the general inverse 
relationship between cell specific growth rate and qP (Dinnis and James 2005; Johari et al. 
2015). 
In addition to promoter-proximal elements and enhancers, endogenous gene 
expression is regulated through the integrated action of various cis-regulatory modules such 
as silencers, insulators and tethering elements. However, many of these elements are not 
required for recombinant protein manufacturing in vitro and contribute to 
unpredictable/uncontrollable gene expression (e.g., Thaisuchat et al. 2011). Specifically 
designed, rather than evolved, our synthetic promoters do not have such functionally 
redundant elements, permitting precise regulation of recombinant transcriptional activity in 
CHO cells via specific TFRE stoichiometry and with relatively small promoter size. 
Moreover, de novo design of promoters also offers additional advantages beyond high level 
transcriptional activity. For example we indirectly showed that synthetic promoters can be 
designed with reduced promoter interference effects by constructing promoters containing 
distinct TFRE types, making them highly desirable in applications such as multigene vectors. 
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Although we did not deliberately design and test our promoters for expression stability in 
stable transfectants, our previous work (Brown et al. 2017) has also demonstrated that it is 
entirely feasible to minimize the number of CpG dinucleotides within each construct, thus 
preventing the formation of methylation-mediated epigenetic silencing associated with 
production instability (Kim et al. 2011). Further, as gene silencing can also be caused by 
deletion of DNA segments via homologous recombination (Jasin and Rothstein 2013), 
TFREs can be organized in particular configurations to specifically avoid the occurrence of 
repeat sequences. 
Numerous families of TFs have been identified, and their activities are regulated by a 
variety of mechanisms including interactions with other TF proteins (TF±TF) or DNA 
binding elements (TF±TFRE), as well as the posttranslational modification state of the TFs 
(Lambert et al. 2018; Pan et al. 2010). Our comparative transient expression analyses 
UHYHDOHGWKDWWKHV\QWKHWLFSURPRWHUDFWLYLW\ZDVSULPDULO\DIXQFWLRQRIDSURPRWHU¶VUHODWLYH
compositiRQRI1)ț%*$%3ȕDQG'037)5(V7DEOHV2 and 3). However, considering 
the composition of promoters 1/09 and 2/08, our stable expression data did not support the 
FRQFOXVLRQWKDW1)ț%*$%3ȕDQG'037)5(EORFNVDORQHFRXOGVXSSRUWKLJK
transcriptional activity in biphasic fed-batch production processes ² clearly a combination of 
a range of TFREs at the appropriate stoichiometry is necessary. For example the relatively 
ZHDNHUSURPRWHUZDVKLJKO\ELDVHGWRZDUGV1)ț%DQG*$%3ȕDQGODFNHG6SVLWHV
1)ț% a transcription factor associated with uncontrolled proliferation and suppressed 
apoptosis in cancer cells (Dolcet et al. 2005) is likely to be downregulated in stationary phase 
and was reported not to be induced by mild hypothermia in HeLa cells (Eskla et al. 2018). 
Unsurprisingly, bioinformatic analysis in this study indicated that endogenous promoters with 
high transcriptional activity throughout the bioproduction process contained more discrete 
TFRE types (Figure 2), whereas CMV contains at least 12 identifiable TFRE types (Brown et 
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al. 2015) making it (sub-optimally) active in stationary phase and hypothermic condition. 
Therefore, whilst as few as 4 TFRE types are required to achieve high transcriptional power 
under a specific condition (e.g. promoter 2/10; Brown et al. 2014), increased promoter 
complexity may confer additional advantages in dynamic bioprocess conditions. 
Lastly, the synthetic promoter design methodology described here is applicable to 
other industrially relevant cell lines or the development of novel gene therapies with higher 
specific activity. With regard to the latter, given the fact that TFREs are derived from 
endogenous components, it may possible to design promoters entirely in silico IURPµRPLF
datasets, obviating the need to test and characterize each TFRE in vitro using model cells 
(which themselves may have altered transcriptional landscape compared to cells in vivo). 
With regard to the former, the lack of high-quality, annotated reference genome sequences of 
such cell lines can be circumvented by using reference genome homologs. For instance, 
transcriptomic analyses of HEK293 (Lin et al. 2014) and BHK cell lines (Johnson et al. 2014) 
against human and Chinese hamster genomes, respectively, revealed a high degree of 
homology. Further, production cell lines share some major phenotypic traits, e.g. their 
acquired ability to proliferate indefinitely and adapt to suspension culture. Therefore, the 
regulation mechanisms of housekeeping/major genes utilized in this study (e.g. Actb, Gapdh, 
Hspa5) are likely to be comparable across different cell line hosts and consequently we 
expect there will be significant TFRE overlaps between them. Through in vitro use of parallel 
high-throughput screening techniques, tens of TFRE parts can be characterized 
simultaneously, enabling confident prediction of their functionality. Accordingly, we should 
now be able to equip any mammalian cell with new machinery and processing capability 
optimally suited for a specific intended purpose. Underpinning this advance is our ability to 
H[SDQGWKHSURPRWHUGHVLJQVSDFHXVLQJWKHHPHUJHQWWRROVRIµRPLFDQGV\QWKHWLFELRORJ\
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whilst combinatorial, context-dependent empirical modeling will further assist the 
construction of the optimal promoter for a specific application. 
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FIGURE LEGENDS 
 
Figure 1. Summary of bioinformatic analysis (Steps 1±4) followed by in vitro screening 
(Step 5) to obtain active TFREs for the design of CHO synthetic promoters for biphasic 
production processes. 
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Figure 2. Distribution of discrete transcription factor regulatory elements (TFREs) across 
high, medium and low transcriptional activity groups. CHO-K1 endogenous promoters with 
high, medium and low transcriptional activities (50 promoters in each group; Supplementary 
Table S1) were surveyed for the presence of discrete TFREs using Genomatix Gene 
Regulation software. TKHUHJLRQíWRUHODWLYHWRSUHGLFWHG766VZDVDQDO\]HG
against a murine promoter background to find overrepresented TFREs in each group. In order 
to identify potentially active TFREs in the high activity group, TFREs that also occurred in 
the medium and/or low activity groups were excluded and the remaining TFREs were 
narrowed down to 32 as described in text. DNA sequences of the selected TFREs are listed in 
Table 1. 
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Figure 3. Screening discrete transcription factor regulatory element activity in CHO-K1 
cells. A: Six copies of each enhancer elements (as described in Table 1) were cloned in series 
upstream of a minimal CMV core promoter in reporter vectors encoding SEAP. B: The 
minimal CMV core promoter (containing a TATA-box and Inr) was modified to include core 
promoter elements MTE and/or DPE at specific positions from Inr while TATA-less core 
promoters were created by mutating the TATA box sequence. The core promoters were 
inserted upstream of the SEAP ORF of promoterless, enhancerless vectors. 6 µg of plasmid 
was transfected into 5×106 CHO-K1SV cells by electroporation followed by culture in 
TubeSpin bioreactors at 37°C. SEAP level in cell culture supernatant was measured 48 h 
post-transfection. Data are expressed as a fold-change with respect to the cell specific 
production rate (qP) of a vector containing only a minimal, wild-type CMV core promoter 
(Core). Data shown are the mean value ± standard deviation of three biological and three 
technical replicates. 
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Figure 4. Measurement of synthetic promoter activity in CHO-K1 cells. Nine synthetic 
promoters comprising Library 1 (A) and ten synthetic promoters comprising Library 2 (B; 
TFRE compositions described in Table 2) were transfected into CHO-K1 cells (4 µg plasmid 
per 5×106 cells). SEAP level in cell culture supernatant and SEAP mRNA level in cells were 
analyzed 48 h post-transfection. Data are expressed as a fold-change with respect to the qP 
(Ŷ) and mRNA abundance (ƑH[KLELWHGE\WKHFRQWURO&09SURPRWHU,QA, SEAP 
expression driven by the SV40 promoter was also tested and in B, the SEAP expression from 
the most active promoter from the first library (1/09) is shown as a striped bar. Data shown 
are the mean value ± standard deviation of two independent experiments each performed in 
duplicate. 
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Figure 5. Generation and analysis of CHO stable transfectant pools expressing recombinant 
SEAP under the control of natural and synthetic promoters. For each promoter, 5×106 GSíí 
CHO-K1 cells were electroporated in quadruplicate with 4 µg plasmid containing a GS gene 
driven by an SV40 promoter and a SEAP gene driven by either a CMV or synthetic promoter 
ZLWKRXWíRUZLWKLQWURQ$IROORZHGE\VHOHFWLRQLQJOXWDPLQH-free media. Transfected 
cells were cultured in TubeSpin bioreactors at 37°C with cell viability measured 2 h post-
WUDQVIHFWLRQGDWDQRWVKRZQ&XOWXUHPHGLDZDVFKDQJHGHYHU\(?GD\VXQWLOWKH
cell viability reached >95% and the stable pools were cryopreserved. A: Measurement of cell 
viability at Day 1 (black circles), Day 7 (gray circles) and Day 13 (open circles) post-
transfection. Each circle represents a transfection pool. B: Measurement of SEAP expression 
(96 h culture) on the fourth passage post-cell revival. Each circle represents a stable pool and 
the horizontal bars represent the mean of the SEAP expression for each promoter. Data is 
QRUPDOL]HGZLWKUHVSHFWWRH[SUHVVLRQRI&09íC: 1.5×106 cells from the four stable 
pools of a specific promoter in B were combined and the SEAP mRNA and GS mRNA 
(expressed by SV40) levels were quantified. Data shown is the mean value ± standard 
GHYLDWLRQRIWKUHHWHFKQLFDOUHSOLFDWHVQRUPDOL]HGZLWKUHVSHFWWRH[SUHVVLRQRI&09í
Mean values significantly different (two-tailed Students t-test) from the expression of 
&09íYDOXHVDUHLQGLFDWHGE\DVWHULVNVP<0.05, **P<0.01, ***P<0.001). 
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Figure 6. Synthetic promoters exhibit improved biomanufacturing performance during fed-
batch culture. Stable transfectant pools expressing recombinant SEAP under the control of 
the CMV promoter or synthetic promoters 1/09 and 2/08 were subjected to a fed-batch 
production process in Erlenmeyer flasks. A: Viable cell concentration was measured over the 
course of 10 days for cultures under normal 37°C condition or 11 days for cultures with a 
shift to 32°C at Day 6 until cell viability dropped below 80%. B: qP at log phase (Day 0±6) 
and stationary phase (Day 6±9) were quantified by measuring the integral viable cell density 
(IVCD) and SEAP titer at Days 6 and 9. Data are normalized with respect to CMV culture 
under normal condition. Data shown are the mean value ± standard deviation of two 
biological and two technical replicates. 
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LIST OF TABLES 
 
Table 1. DNA sequence of potentially active transcription factor regulatory elements 
identified by bioinformatic survey of endogenous CHO-K1 promoters. Measurement of the 
relative ability of TFREs to activate transcription of recombinant SEAP genes in CHO-K1 
cells is shown in Figure 3. 
 
Transcription factor regulatory element Binding site 
(QKDQFHUHOHPHQWV  
 $FWLYDWRUSURWHLQ$3 77*&&7****&7$7 
 Aryl hydrocarbon receptor and nuclear translocator 
KHWHURGLPHU$K5$517 
*77*&*7*&*$$ 
 &DOFLXPUHVSRQVHIDFWRU&D5) $*$$&*$**&$ 
 &&$$7HQKDQFHUELQGLQJSURWHLQHSVLORQ&(%3İ $77*&*&$$7 
 &\FOLQ'LQWHUDFWLQJ0\EOLNHSURWHLQ'03 *$&&&**$7*7$* 
 'HOWDODFWRIHUULQǻ/I **&$&77*& 
 ()WUDQVFULSWLRQIDFWRU() *&7&**&*&&$$$& 
 Early growth response protein 1(*5 $7*&*7***&*7 
 (U\WKURLG.UXHSSHOOLNHIDFWRU(./) &$***$***7* 
 (VWURJHQUHODWHGUHFHSWRUDOSKD(55Į 7&&$$**7&$&$ 
 *$ELQGLQJSURWHLQEHWD*$%3ȕ &&&&**$$*7*$& 
 GLI family zinc finger protein 2*/, *$&&$&&&$$* 
 *OLDOFHOOVPLVVLQJKRPRORJ*&0 $$$&&&*&$7$7 
 *XWHQULFKHG.UXHSSHOOLNHIDFWRU*./) $7&$&$**$77 
 0\HORLG]LQFILQJHU0=) 7**7****$**** 
 1XFOHDUIDFWRUNDSSD%1)ț% 7***$&777&&$ 
 1XFOHDUIDFWRUNDSSD%S1)ț%S 77****$777&&&$ 
 2RF\WHVSHFLILFKRPHRER[2ER[ 7$*77$$7&&&&&7 
 3DLUHGER[SURWHLQ3D[3D[ 7&*7&$&*&77&$ 
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 3DLUHGER[SURWHLQ3D[3D[ *7&$&*&$7*$&7*& 
 5DW2OI(%)DVVRFLDWHG=QILQJHUSURWHLQ52$= **&$&&&$$***7*$ 
 6LJQDOWUDQVGXFHUDFWLYDWRURIWUDQVFULSWLRQ67$7 $777&&&**$$$7* 
 6WHUROUHJXODWRU\HOHPHQWELQGLQJSURWHLQ	65(%3 $$7&$&&&&$&7*& 
 6WLPXODWLQJSURWHLQ6S $****&****7 
 7FHOOOHXNHPLDKRPHRER[7/; &**7$$77** 
 8SVWUHDPVWLPXODWLQJIDFWRU86) ***7&$&*7** 
 9LUDOMyb proteinY0\E 777$$&**&$$ 
 :LOPVWXPRUVXSSUHVVRU:7 7*&*7***$*7$* 
 =LQFILQJHU%('W\SHFRQWDLQLQJ=%(' 7*7&*&*$&$ 
&RUHSURPRWHUHOHPHQWV  
 'RZQVWUHDPSURPRWHUHOHPHQW'3( $*$&*7*&&7 
 ,QLWLDWRU,QU TCAGAT 
 0RWLIWHQHOHPHQW07( &&*$*&**$*& 
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Table 2. Composition of specific TFRE copies in synthetic promoters. A two-level factorial 
design with a center point (marked with an asterisk [*]) using six factors (NFțB, *$%3ȕ
'03$K5$51786)67$7) was used to design the first library of nine synthetic 
promoters with different TFRE compositions biased towards more active TFREs. A reduced 
two-factor interaction model was employed with the low and high levels for NFțB, *$%3ȕ
DQG'03VHWWRWZRDQGVL[FRSLHVUHVSHFWLYHO\DQGWKHORZDQGKLJKOHYHOVIRU
$K5$51786)DQG67$7VHWWRRQHDQGWKUHHFRSLHVUHVSHFWLYHO\ Additionally, one 
copy of Sp1 is added to each promoter. Derived from the expression analysis of the first 
library promoters (Figure 4A), a two-level factorial design using four factors (NFțB, 
*$%3ȕ86)67$7) was used to design a second library of eight promoters with different 
TFRE compositions further biased towards highly active TFREs. '03DQG$K5$517
ZHUHDGGHGDWPLGOHYHOVWRVXSSRUWEDVDOH[SUHVVLRQTwo potentially strong promoter 
designs not covered in the DOE (marked with double asterisks [**]) were also constructed. 
The arrangement of TFRE copies was randomized using R software, chemically synthesized 
and inserted upstream of the minimal CMV core promoter in SEAP reporter plasmids. 
 
Promoter NFțB GABPȕ DMP1 AhR/ 
ARNT 
USF1 STAT3 Sp1 Total 
Library 1         
1/01 2 2 2 3 3 3 1 16 
1/02 2 2 6 3 1 1 1 16 
1/03 2 6 2 1 3 1 1 16 
1/04 6 2 2 1 1 3 1 16 
1/05* 4 4 4 2 2 2 1 19 
1/06 2 6 6 1 1 3 1 20 
1/07 6 2 6 1 3 1 1 20 
1/08 6 6 2 3 1 1 1 20 
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1/09 6 6 6 3 3 3 1 28 
Library 2         
2/01 3 3 4 2 1 1 ± 14 
2/02 3 3 4 2 3 3 ± 18 
2/03 3 7 4 2 1 3 ± 20 
2/04 3 7 4 2 3 1 ± 20 
2/05 7 3 4 2 1 3 ± 20 
2/06 7 3 4 2 3 1 ± 20 
2/07 7 7 4 2 1 1 ± 22 
2/08 7 7 4 2 3 3 ± 26 
2/09** 7 6 5 4 3 2 ± 27 
2/10** 7 7 7 7 ± ± ± 28 
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Table 3. Summary of DOE analysis of effectors and effector interactions controlling SEAP 
gene expression in synthetic promoters. Using cell specific production rate (qP) as output 
variable, reduced two-factor interaction (2FI) models were used to compare the impact of 
specific TFREs and the presence of interactions among them, with p < 0.05 considered to be 
significant. The alias structures/confounding factors are as follows: First synthetic promoter 
library; A = A + BD + CE, B = B + AD + CF, C = C + AE + BF, D = D + AB + EF, E = E + 
AC + DF, F = F + BC + DE, AF = AF + BE + CD; Second synthetic promoter library; A = A, 
B = B, C = C, D = D, AB = AB + CD, AC = AC + BD, AD = AD + BC. 
 
Factor 
Sum of 
squares 
p-value Signif. 
Model predictability 
(Pred/AdjR2) 
Library 1     
Model 50.82 <0.001 Yes 0.42/0.61 
$1)ț% 20.65 <0.001 Yes  
%*$%3ȕ 19.55 <0.001 Yes  
C: DMP1 8.48 0.012 Yes  
D: AhR/ARNT 1.28 0.296 No  
E: USF1 0.76 0.417 No  
F: STAT3 0.10 0.766 No  
$)1)ț%67$7 ± ± ±  
Library 2     
Model 94.05 0.001 Yes 0.36/0.51 
$1)ț% 50.94 0.001 Yes  
%*$%3ȕ 35.00 0.004 Yes  
C: USF1 4.12 0.281 No  
D: STAT3 3.99 0.289 No  
$%1)ț%*$%3ȕ ± ± ±  
$&1)ț%86) ± ± ±  
$'1)ț%67$7 ± ± ±  
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